@rubicon59 You put this on my radar at $11. Was a no brainer on earnings inflection and valuation then, and I agree still cheap today. If you have a preferred charity, I’d be happy to make a donation.
@valuedontlie I like the recent acquisitions though time will tell on success in launching a antibiotic spec pharma biz. Don't have great insight but the minority equity stakes don't seem great. Armata looks challenged given cash burn.
@ltmleverage fair, they’ll have to cut guide and have lost credibility. ahco getting their lunch eaten by OMI and blowing out mgmt doesn’t give me confidence in ability to generate growth of fcf.
@timrhughes @JustTheFacts37 @SterlingTakes@JonSchweppe @JDVance1 And allowing them to be dischargeable will send tuition even higher because colleges and students know the government will pick up the tab on the discharge, no reason for any discipline.